Market Access and Implementation

A*STAR collaborates with a wide range of partners and ecosystems to facilitate the end-to-end productisation and market access of innovative solutions.

These collaborations ensure that groundbreaking research and technologies effectively reach the market, addressing unmet clinical needs and driving economic growth.

Validating Unmet Clinical Needs


 

Areas covered
Partners in Validating Unmet Clinical Needs

A*STAR works with all 3 of our local healthcare clusters i) National University Health System, ii) National Healthcare Group iii) Singapore Health Services and national platforms i.e. Singapore Biodesign to understand unmet clinical needs.

This ensures that research and innovations are closely aligned with real-world healthcare challenges, paving the way for practical and impactful solutions

 

Tech & Product Development


 

Tech and product development
Tech & Product Development Partners
As A*STAR looks to advance this technology research into products, it also houses key national platforms that support the continuum of MedTech products across in-vitro diagnostics, digital health and medical devices. 

For in-vitro diagnostics, the Diagnostics Development (DxD) Hub provides verification and validation of in-vitro diagnostics (IVDs) to ensure market readiness.

The Digital Health Accelerator supports digital engineering, deployment, and scaling of digital health solutions.

The MedTech Catapult offers in-house product development support for Life Science Tools and Medical Devices with local contract manufacturers.

Market Access and Fundraising


 

Market Access and Fundraising
Market Access & Fundraising Partners
A*STAR is committed to supporting our technologies to market through from venture co-creation to incubation and global partners for market access.

For example, A*START Central, co11ab Novena provides co-working space, furnished laboratories and entrepreneurial support to our MedTech startups whilst A*STAR Partners Center is our outpost in Suzhou for A*STAR spin-offs wanting to enter the China market. 

Finally, we partner globally for market validation and testing. This includes the likes of Cedars SinaiFogarty Institute for Innovation in the US and the ASEAN Dx Initiative through our national platforms.